Skip to main content
. 2018 Oct 25;2018:5359208. doi: 10.1155/2018/5359208

Table 7.

Results of the Consensus Conference on the use of betahistine in comorbidity cases. 1 = absolutely disagree, 2 = disagree, 3 = agree, 4 = more than agree, and 5 = absolutely agree. Consensus was reached when the sum of items 1 and 2 or 3, 4, and 5 reached 66%. Same asterisk convention.

1 2 3 4 5

In case of comorbid migraine:

1. I do not use betahistine 21% 47% 23% 4% 4%

69%  31%

2. I use an association of betahistine plus an antimigraine drug 1% 13% 47% 20% 19%

14% 86% ∗∗∗

3. I use only betahistine 25% 66% 9% 0% 0%

91%  9%

In case of comorbid anxiety and/or depression:

4. I do not use betahistine 33% 51% 9% 4% 3%

84%  16%

5. I use an association of betahistine plus an anxiolytic and/or antidepressant drug 4% 3% 49% 23% 21%

7% 93% ∗∗∗

6. I use only Betahistine 37% 51% 10% 1% 1%

88%  12%